Pfizer the world's leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines, oncology products and consumer medicines (62.3%); - generic medicines (37.7%): for treating cardio-vascular diseases, nervous system disorders, infectious and respiratory diseases, Is Pfizer Inc. (PFE) Stock a Good Buy? - InvestorsObserver Pfizer Inc. stock is down -23.99% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives PFE stock a score of 28 out of a possible 100.. That rank is primarily influenced by a short-term technical score of 1. PFE's rank also includes a long-term technical score of 36. Why Pfizer Stock Continues to Tank after Mylan Deal ... Jul 31, 2019 · Pfizer stock (PFE) has fallen 10% in the past two days on its deal with Mylan (MYL) and its lower earnings guidance. The company also lowered its price target from $49 to $41. Standpoint Research slashes price target on Pfizer Inc ...
Pfizer (NYSE:PFE) price target set to $46.00 by JPMorgan ...
Pfizer Inc. (PFE) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Pfizer Inc. (PFE) stock, price quote and chart, trading and investing tools. Pfizer's Push For Antisense Licensing Is Closely Aligned With Current Target Pfizer (NYSE:PFE) Price Target Cut to $44.00 by Analysts ... 7 days ago · Pfizer (NYSE:PFE) had its target price lowered by Royal Bank of Canada from $46.00 to $44.00 in a research report released on Friday morning, AnalystRatings.com reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. Investing in Pfizer (PFE) Stock Now May Be Worthwhile ... Nov 13, 2019 · With PFE stock, it’s important to realize that investors and analysts are looking at a moving target. The Pfizer of 2025 is going to look far different from the Pfizer of 2005 or 2015. Pfizer - PFE - Stock Price & News | The Motley Fool
Pfizer Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PFE updated stock price target summary.
Pfizer Analysts - Markets Insider: Stock Market News ... Pfizer Analysts: This is the Analysts-site for the company Pfizer on Markets Insider. Price Target Summary for Pfizer PRICE TARGET No. of Brokers 12
Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering ...
Standpoint Research slashes price target on Pfizer Inc ... The new note on the price target was released on February 27, 2020, representing the official price target for Pfizer Inc. stock. The Average True Range (ATR) for Pfizer Inc. is set at 1.03, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 3.74. The Price to Book ratio for the last quarter was 3.04 PFE Stock Quote - Pfizer, Inc. Common Stock Price - Nasdaq Mar 27, 2020 · Stock quote for Pfizer, Inc. Common Stock Common Stock (PFE) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Pfizer (PFE) Stock: Price, Quote and Overview | Stock Analysis Get real-time information and analysis on Pfizer Inc. (PFE) stock today, including the current stock price quote and key metrics. Get real-time information and analysis on Pfizer Inc. (PFE) stock today, including the current stock price quote and key metrics. *Average 12-month price target from 12 stock analysts. Financial Performance Pfizer Bought Penny Biotech Stock ContraFect Just Before ...
In depth view into PFE (Pfizer) stock including the latest price, news, dividend history, earnings information and financials.
Is Pfizer Inc. (PFE) Stock a Good Buy? - InvestorsObserver Pfizer Inc. stock is down -23.99% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives PFE stock a score of 28 out of a possible 100.. That rank is primarily influenced by a short-term technical score of 1. PFE's rank also includes a long-term technical score of 36. Why Pfizer Stock Continues to Tank after Mylan Deal ... Jul 31, 2019 · Pfizer stock (PFE) has fallen 10% in the past two days on its deal with Mylan (MYL) and its lower earnings guidance. The company also lowered its price target from $49 to $41. Standpoint Research slashes price target on Pfizer Inc ... The new note on the price target was released on February 27, 2020, representing the official price target for Pfizer Inc. stock. The Average True Range (ATR) for Pfizer Inc. is set at 1.03, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 3.74. The Price to Book ratio for the last quarter was 3.04 PFE Stock Quote - Pfizer, Inc. Common Stock Price - Nasdaq